{ "company_number": "07581177", "name": "Empire Medicines Limited", "url": "/company/07581177", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2011-03-28", "dissolved_on": null, "sic_codes": [ { "code": "86900", "description": "Other human health activities", "section": "Q", "section_name": "Human health and social work activities", "url": "/sic/86900" } ], "registered_address": { "id": 2364342, "url": "/address/2364342", "line1": "234 SEYMOUR GROVE", "line2": "", "post_town": "MANCHESTER", "county": "", "country": "ENGLAND", "postcode": "M16 0DT" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07581177", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-12-31", "last_made_up": "2025-03-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/07581177/accounts/2025-03-31", "pdf_url": "/company/07581177/accounts/2025-03-31.pdf", "made_up_date": "2025-03-31", "period_start": "2025-03-31", "period_end": "2025-03-31", "entity_name": "Empire Medicines Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "34665.00", "debtors": "111515.00", "cash_bank_in_hand": "66019.00", "current_assets": "200736.00", "creditors_due_within_one_year": "96220.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "104516.00", "total_assets_less_current_liabilities": "139181.00", "net_assets_liabilities": "132595.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "132593.00", "shareholder_funds": "132595.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2025.zip" }, { "url": "/company/07581177/accounts/2024-03-31", "pdf_url": "/company/07581177/accounts/2024-03-31.pdf", "made_up_date": "2024-03-31", "period_start": "2024-03-31", "period_end": "2024-03-31", "entity_name": "Empire Medicines Limited", "dormant": false, "average_employees": "5.00", "tangible_fixed_assets": "40593.00", "debtors": "106393.00", "cash_bank_in_hand": "463950.00", "current_assets": "593545.00", "creditors_due_within_one_year": "454665.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "138880.00", "total_assets_less_current_liabilities": "179473.00", "net_assets_liabilities": "171760.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "171758.00", "shareholder_funds": "171760.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2024.zip" }, { "url": "/company/07581177/accounts/2023-03-31", "pdf_url": "/company/07581177/accounts/2023-03-31.pdf", "made_up_date": "2023-03-31", "period_start": "2023-03-31", "period_end": "2023-03-31", "entity_name": "Empire Medicines Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "48005.00", "debtors": "93775.00", "cash_bank_in_hand": "422494.00", "current_assets": "539471.00", "creditors_due_within_one_year": "421371.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "118100.00", "total_assets_less_current_liabilities": "166105.00", "net_assets_liabilities": "156984.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "156982.00", "shareholder_funds": "156984.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2023.zip" }, { "url": "/company/07581177/accounts/2022-03-31", "pdf_url": "/company/07581177/accounts/2022-03-31.pdf", "made_up_date": "2022-03-31", "period_start": "2022-03-31", "period_end": "2022-03-31", "entity_name": "Empire Medicines Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "57550.00", "debtors": "167870.00", "cash_bank_in_hand": "313394.00", "current_assets": "499466.00", "creditors_due_within_one_year": "402218.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "97248.00", "total_assets_less_current_liabilities": "154798.00", "net_assets_liabilities": "143863.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "143861.00", "shareholder_funds": "143863.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2022.zip" }, { "url": "/company/07581177/accounts/2021-03-31", "pdf_url": "/company/07581177/accounts/2021-03-31.pdf", "made_up_date": "2021-03-31", "period_start": "2021-03-31", "period_end": "2021-03-31", "entity_name": "Empire Medicines Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "69514.00", "debtors": "180915.00", "cash_bank_in_hand": "264856.00", "current_assets": "467185.00", "creditors_due_within_one_year": "409474.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "57711.00", "total_assets_less_current_liabilities": "127225.00", "net_assets_liabilities": "114017.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "114015.00", "shareholder_funds": "114017.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2021.zip" }, { "url": "/company/07581177/accounts/2020-03-31", "pdf_url": "/company/07581177/accounts/2020-03-31.pdf", "made_up_date": "2020-03-31", "period_start": "2020-03-31", "period_end": "2020-03-31", "entity_name": "Empire Medicines Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "7606.00", "debtors": "190682.00", "cash_bank_in_hand": "145830.00", "current_assets": "360305.00", "creditors_due_within_one_year": "339265.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "21040.00", "total_assets_less_current_liabilities": "28646.00", "net_assets_liabilities": "25881.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "25879.00", "shareholder_funds": "25881.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2021.zip" }, { "url": "/company/07581177/accounts/2019-03-31", "pdf_url": "/company/07581177/accounts/2019-03-31.pdf", "made_up_date": "2019-03-31", "period_start": "2019-03-31", "period_end": "2019-03-31", "entity_name": "Empire Medicines Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "9340.00", "debtors": "248541.00", "cash_bank_in_hand": "95897.00", "current_assets": "366068.00", "creditors_due_within_one_year": "304018.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "62050.00", "total_assets_less_current_liabilities": "71390.00", "net_assets_liabilities": "68295.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "68293.00", "shareholder_funds": "68295.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2019.zip" }, { "url": "/company/07581177/accounts/2018-03-31", "pdf_url": "/company/07581177/accounts/2018-03-31.pdf", "made_up_date": "2018-03-31", "period_start": "2018-03-31", "period_end": "2018-03-31", "entity_name": "Empire Medicines Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "11509.00", "debtors": "159219.00", "cash_bank_in_hand": "117756.00", "current_assets": "298605.00", "creditors_due_within_one_year": "263176.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "35429.00", "total_assets_less_current_liabilities": "46938.00", "net_assets_liabilities": "43431.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "43429.00", "shareholder_funds": "43431.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2018.zip" }, { "url": "/company/07581177/accounts/2017-03-31", "pdf_url": "/company/07581177/accounts/2017-03-31.pdf", "made_up_date": "2017-03-31", "period_start": "2017-03-31", "period_end": "2017-03-31", "entity_name": "Empire Medicines Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "14236.00", "debtors": "112525.00", "cash_bank_in_hand": "103984.00", "current_assets": "219639.00", "creditors_due_within_one_year": "190355.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "29284.00", "total_assets_less_current_liabilities": "43520.00", "net_assets_liabilities": "40673.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "40671.00", "shareholder_funds": "40673.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2017.zip" }, { "url": "/company/07581177/accounts/2016-03-31", "pdf_url": "/company/07581177/accounts/2016-03-31.pdf", "made_up_date": "2016-03-31", "period_start": "2016-03-31", "period_end": "2016-03-31", "entity_name": "Empire Medicines Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "16426.00", "debtors": "115096.00", "cash_bank_in_hand": "33815.00", "current_assets": "152146.00", "creditors_due_within_one_year": "138667.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "13479.00", "total_assets_less_current_liabilities": "29905.00", "net_assets_liabilities": "26620.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "26619.00", "shareholder_funds": "26620.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2016.zip" }, { "url": "/company/07581177/accounts/2015-03-31", "pdf_url": "/company/07581177/accounts/2015-03-31.pdf", "made_up_date": "2015-03-31", "period_start": "2015-03-31", "period_end": "2015-03-31", "entity_name": "Empire Medicines Limited", "dormant": true, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "1.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": "1.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2015.zip" }, { "url": "/company/07581177/accounts/2013-03-31", "pdf_url": "/company/07581177/accounts/2013-03-31.pdf", "made_up_date": "2013-03-31", "period_start": "2013-03-31", "period_end": "2013-03-31", "entity_name": "Empire Medicines Limited", "dormant": true, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "10.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": "10.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "10.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2013.zip" }, { "url": "/company/07581177/accounts/2012-03-31", "pdf_url": "/company/07581177/accounts/2012-03-31.pdf", "made_up_date": "2012-03-31", "period_start": "2012-03-31", "period_end": "2012-03-31", "entity_name": "Empire Medicines Limited", "dormant": true, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "10.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": "10.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "10.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2012.zip" } ], "pdf_only_filings": [ { "made_up_date": "2014-03-31", "filing_date": "2014-07-01", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/07581177/accounts/2014-03-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07581177/filing-history/MzEwMjg4MzI4MWFkaXF6a2N4/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/07581177/filing-history" }, "confirmation_statement": { "next_due": "2027-01-06", "last_made_up": "2025-12-23" }, "officers": [], "psc": [ { "name": "Miss Aysha Saman", "kind": "individual-person-with-significant-control", "person_url": "/person/574957", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Mr Haroon Mohammad Iqbal", "kind": "individual-person-with-significant-control", "person_url": "/person/1841871", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-13T04:32:18.465226+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }